Pennant Group, Inc. (PNTG) stock
PNTGNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3023% above fair value
$36.50−0.53 (-1.43%)
Close on Nov 17, 2026Market cap $1.27BP/E 40.6Yield –
Pennant r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Pennant
Pennant has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?